SK
Sanjiv Kumar Singh
About Sanjiv Kumar Singh
Sanjiv Kumar Singh has 13 years in corporate governance. Holds Director role. Currently with 4 companies, including Medizin Biopharma Private Limited and Shyp Healthcare Private Limited. Formerly with 1 company. Engaged in General Business, Healthcare. Contributes to corporate operations.
Current companies
| Company | Designation | Appointment | Founded | Status |
|---|---|---|---|---|
Shyp Healthcare Private Limited
U85190BR2022PTC059120
|
Director | 22 Jul 2022 | 2022 | Active |
Reform Hospital Private Limited
U86100BR2025PTC079120
|
Director | 20 Sep 2025 | 2025 | Active |
Healing Hands Advanced Care Solutions Private Limited
U46497BR2025PTC078900
|
Director | 11 Sep 2025 | 2025 | Active |
Reform Institute Of Medical Sciences Private Limited
U86100BR2024PTC067671
|
Director | 10 Feb 2024 | 2024 | Active |
Previous companies
| Company | Designation | Appointment | Founded | Status |
|---|---|---|---|---|
Medizin Biopharma Private Limited
U52310BR2013PTC019964
|
Director | 07 Mar 2013 | 2013 | Strike Off |
Explore Director's current and past company associations Uncover their professional journey today!
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Sanjiv Kumar Singh
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Sanjiv Kumar Singh
Sanjiv Kumar Singh has 13 years in corporate governance. Holds Director role. Currently with 4 companies, including Medizin Biopharma Private Limited and Shyp Healthcare Private Limited. Formerly with 1 company. Engaged in General Business, Healthcare. Contributes to corporate operations.
Sanjiv Kumar Singh is associated with 4 companies as Director.
Sanjiv Kumar Singh has expertise in General Business, Healthcare.
Sanjiv Kumar Singh has 13 years in corporate governance.